PollNowData
Back to companies

Immunovant, Inc.

IMVTUSNASDAQPharmaceuticals & Healthcare

Immunovant, Inc.

Revenue
—
FY2026
Operating income
-$505.4mn
FY2026
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API